Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics Inc. (DMAC) Net Cash Flow (2018 - 2019)

DiaMedica Therapeutics (DMAC) has 2 years of Net Cash Flow data on record, last reported at -$858000.0 in Q4 2019.

  • For Q4 2019, Net Cash Flow fell 106.64% year-over-year to -$858000.0; the TTM value through Dec 2019 reached -$12.9 million, down 183.65%, while the annual FY2024 figure was -$1.5 million, 720.54% down from the prior year.
  • Net Cash Flow reached -$858000.0 in Q4 2019 per DMAC's latest filing, down from $1.8 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $12.9 million in Q4 2018 and bottomed at -$14.1 million in Q1 2019.